OncoGenex Pharmaceuticals Lands $9,500,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed5fe3e3-b4dc-4288-8316-fbe23941db26&Preview=1 -
Date
7/20/2009 -
Company Name
OncoGenex Pharmaceuticals -
Mailing Address
1522 217th Place SE Bothell, WA 98021 -
Company Description
OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. We have a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. -
Website
http://www.oncogenex.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$9,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
